A large, multi-center study released by the Centers for Disease Control and Prevention (CDC) on Friday found that people with Covid-19 are at greater risk for myocarditis and other inflammation of the heart.

The CDC reported that myocarditis or pericarditis was more likely after Covid infection than it was after Moderna, Pfizer, and Moderna vaccines for males and females aged 5 to 64. According to the CDC, however, such cardiac diseases are uncommon after vaccination and infection.

Pericarditis and myocarditis are both inflammations of the inner heart muscle. Multisystem inflammation is an infection of Covid that can affect multiple organs.

Moderna and Pfizer’s vaccines were associated with an increase in myocarditis risk after receiving the second dose. The highest incidence was seen among 12- and 17-year-old boys. The CDC found that even within this age group, myocarditis/pericarditis rates were higher following Covid vaccination than they were after vaccination.

Teenage boys had a higher rate of myocarditis and pericarditis than the average person after receiving the first vaccine. This was compared with the 22 to 23 cases for each 100,000 who received the second dose. The risk of developing heart disease after Covid infection was up 5.6 times greater than the dose that had been given. This risk is up to 69 times greater after infection than it was for the first dose.

Between Jan. 2021 and Jan. 20,22, the CDC reviewed electronic health records for more than 15,000,000 people aged 5 or older in 40 health-care organizations. Researchers compared the risks of developing cardiac disease after Covid infections to those who received Moderna and Pfizer’s vaccines. The comparison did not consider booster doses.

The overall risk of developing heart disease after Covid was between 2 and 115 times more than vaccinations, depending on how old, gender, and what dose was given.

According to the CDC, males between 12 and 39 years of age were listed in February. should consider waiting eight weeksMyocarditis risk can be reduced by vaccinating between the second and third doses of Moderna or Pfizer vaccines. Canadian health officials found that myocarditis rates after Moderna or Pfizer vaccinations were higher if the interval between each dose was less than 30 days.

Moderna’s second dosage appears to be associated with higher myocarditis risk than Pfizer. according to data presentedThe February CDC committee of experts on vaccines. Canadian public health officials in Ontario found that myocarditis rates were five times higher among males aged 18-24 after receiving Moderna twice as often as those who received Pfizer.

According to a CDC survey, most people with myocarditis who received vaccinations were able to recover fully.